• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马洛里小体形成过程中非肝细胞角蛋白的从头表达。

De novo expression of nonhepatocellular cytokeratins in Mallory body formation.

作者信息

Schirmacher P, Dienes H P, Moll R

机构信息

Institute of Pathology, University of Mainz, Germany.

出版信息

Virchows Arch. 1998 Feb;432(2):143-52. doi: 10.1007/s004280050148.

DOI:10.1007/s004280050148
PMID:9504859
Abstract

Mallory bodies (MBs) are eosinophilic cytoplasmic inclusions observed predominantly in alcoholic liver disease. Although linked to disease activity, their pathogenesis is still unclear. Since intermediate filaments (cytokeratins) are major components of MBs, their cytokeratin polypeptide composition was analysed with monospecific antibodies for cytokeratins 7, 8, 14, 18, 19, and 20 by immunohistology. MBs were identified by light microscopy and ubiquitin immunostaining. All MBs were positive for cytokeratins 8 and 18. A significant percentage of the MBs was strongly positive for cytokeratins 19 and/or 20, which are not detectable in hepatocytes of normal liver and, in the case of cytokeratin 20, in hepatocytes of diseases devoid of MBs. MBs were essentially negative for cytokeratins 7 and 14. De novo expression of cytokeratins 19 and 20 was independent of the aetiology, occurring in all MB-associated diseases analysed, and seemed to precede MB formation, since in some hepatocytes a cytoskeletal-type staining pattern for these cytokeratins was present. In hepatocellular carcinomas cytokeratins 19 and 20 were frequently detected, but their cellular distribution was less closely associated with MBs. The ectopic expression of cytokeratins 19 and 20 appears to be related to MB formation and may take part in the derangement of the intermediate filaments during MB formation.

摘要

马洛里小体(MBs)是主要在酒精性肝病中观察到的嗜酸性细胞质内含物。尽管与疾病活动有关,但其发病机制仍不清楚。由于中间丝(细胞角蛋白)是MBs的主要成分,因此通过免疫组织化学用针对细胞角蛋白7、8、14、18、19和20的单特异性抗体分析了它们的细胞角蛋白多肽组成。通过光学显微镜和泛素免疫染色鉴定MBs。所有MBs对细胞角蛋白8和18呈阳性。相当比例的MBs对细胞角蛋白19和/或20呈强阳性,在正常肝脏的肝细胞中检测不到细胞角蛋白19和/或20,就细胞角蛋白20而言,在没有MBs的疾病的肝细胞中也检测不到。MBs对细胞角蛋白7和14基本呈阴性。细胞角蛋白19和20的从头表达与病因无关,在所分析的所有与MB相关的疾病中均有发生,并且似乎先于MB形成,因为在一些肝细胞中存在这些细胞角蛋白的细胞骨架型染色模式。在肝细胞癌中经常检测到细胞角蛋白19和20,但其细胞分布与MBs的关系不太密切。细胞角蛋白19和20的异位表达似乎与MB形成有关,并且可能在MB形成过程中参与中间丝的紊乱。

相似文献

1
De novo expression of nonhepatocellular cytokeratins in Mallory body formation.马洛里小体形成过程中非肝细胞角蛋白的从头表达。
Virchows Arch. 1998 Feb;432(2):143-52. doi: 10.1007/s004280050148.
2
Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.一组抗细胞角蛋白抗体对马洛里小体的免疫组织化学特征。
Med Electron Microsc. 2004 Jun;37(2):114-8. doi: 10.1007/s00795-003-0240-1.
3
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?肿瘤性和非肿瘤性肝细胞中的马洛里小体与细胞内透明小体有关联吗?
J Pathol. 2006 Apr;208(5):653-61. doi: 10.1002/path.1946.
4
The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey).马洛里小体:形态学、临床及实验研究(文献综述的第1部分)
Hepatology. 1994 Oct;20(4 Pt 1):1061-77. doi: 10.1002/hep.1840200440.
5
Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody.
Lab Invest. 1986 May;54(5):543-53.
6
A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.酒精性肝病的细胞角蛋白免疫组织化学研究:肝细胞可表达“胆管型”细胞角蛋白的证据。
Histopathology. 1988 Dec;13(6):605-17. doi: 10.1111/j.1365-2559.1988.tb02092.x.
7
Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis.威尔逊病和非威尔逊病性肝铜中毒中马洛里小体的免疫组织化学分析
Hepatology. 2004 Apr;39(4):963-9. doi: 10.1002/hep.20108.
8
Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.在体外,p38抑制剂可阻止马洛里小体(细胞角蛋白聚集体)的形成。
Exp Mol Pathol. 2006 Jun;80(3):228-40. doi: 10.1016/j.yexmp.2006.01.003. Epub 2006 Mar 23.
9
From Mallory to Mallory-Denk bodies: what, how and why?从马洛里小体到马洛里-登克小体:是什么、如何形成以及为何如此?
Exp Cell Res. 2007 Jun 10;313(10):2033-49. doi: 10.1016/j.yexcr.2007.04.024. Epub 2007 Apr 27.
10
Molecular structural changes in Mallory body proteins in human and mouse livers: an infrared spectroscopy study.人和小鼠肝脏中马洛里小体蛋白的分子结构变化:一项红外光谱研究。
Exp Mol Pathol. 1993 Dec;59(3):197-210. doi: 10.1006/exmp.1993.1039.

引用本文的文献

1
[Diagnosis and differential diagnosis of hepatocellular carcinoma].
Pathologe. 2006 Jul;27(4):294-9. doi: 10.1007/s00292-006-0842-1.
2
Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations.肝脏中播散性结直肠肿瘤细胞的预后价值:随访检查结果
Int J Colorectal Dis. 2004 Jul;19(4):380-6. doi: 10.1007/s00384-003-0555-3. Epub 2003 Nov 21.